Everolimus improves progression-free survival for patients with...
MD Anderson led research in field, from small investigator-initiated studies to international confirmatory trials
MD Anderson News...
Breakthrough study demonstrates survival advantage with...
CheckMate-025 study led by The University of Texas MD Anderson Cancer Center portends paradigm change in standard of care treatment...
MD Anderson study identifies leukemia tumor suppressor
Protein-coding gene hnRNP K may be culprit in acute myeloid leukemia
MD Anderson News Release 09/24/2015
A protein-coding...
A Conversation With a Living Legend® returns to San Antonio to...
Football legend teams up with MD Anderson to support cancer research
MD Anderson News Release 09/22/2015
The University of Texas MD...
MD Anderson, Cayman Chemical, and Fannin Innovation Studio...
ACF Pharmaceuticals to explore the potential of novel, small molecule anti-cancer agents
MD Anderson News Release 09/15/2015
...
MD Anderson immunologist Jim Allison wins Lasker-DeBakey...
Cancer immunotherapy pioneer awarded prestigious U.S. medical research honor
MD Anderson News Release 09/08/2015
For inventing...
MD Anderson and Cellectis announce pre-clinical and...
MD Anderson News Release 09/03/2015
Cellectis, the gene editing company employing proprietary technologies to develop...
MD Anderson brings Making Cancer History® seminar to Atlanta
Free event offers information on the latest cancer treatment and prevention strategies
MD Anderson News Release 09/03/2015...
MD Anderson to honor Houstonians for their efforts to end...
River Oaks Country Club event to pay tribute to Houston community
MD Anderson News Release 09/02/2015
The University...
Michelle Barton receives Rogers Award for Excellence in...
Esteemed educator strives to ‘put the students first’
MD Anderson News Release 09/01/2015
Michelle Barton, Ph.D., professor...